Report Detail

Other Global Recombinant Protein Drugs Market Professional Survey Report 2019

  • RnM2931316
  • |
  • 12 February, 2019
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Other

The global Recombinant Protein Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Recombinant Protein Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Protein Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Protein Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Recombinant Protein Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Recombinant DNA
Recombinant RNA

Segment by Application
Pharmaceutical Industry
Other


Table of Contents

    Executive Summary

      1 Industry Overview of Recombinant Protein Drugs

      • 1.1 Definition of Recombinant Protein Drugs
      • 1.2 Recombinant Protein Drugs Segment by Type
        • 1.2.1 Global Recombinant Protein Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Recombinant DNA
        • 1.2.3 Recombinant RNA
      • 1.3 Recombinant Protein Drugs Segment by Applications
        • 1.3.1 Global Recombinant Protein Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Pharmaceutical Industry
        • 1.3.3 Other
      • 1.4 Global Recombinant Protein Drugs Overall Market
        • 1.4.1 Global Recombinant Protein Drugs Revenue (2014-2025)
        • 1.4.2 Global Recombinant Protein Drugs Production (2014-2025)
        • 1.4.3 North America Recombinant Protein Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Recombinant Protein Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Recombinant Protein Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Recombinant Protein Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Recombinant Protein Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Recombinant Protein Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Recombinant Protein Drugs
      • 2.3 Manufacturing Process Analysis of Recombinant Protein Drugs
      • 2.4 Industry Chain Structure of Recombinant Protein Drugs

      3 Development and Manufacturing Plants Analysis of Recombinant Protein Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Recombinant Protein Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Recombinant Protein Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Recombinant Protein Drugs Production and Capacity Analysis
      • 4.2 Recombinant Protein Drugs Revenue Analysis
      • 4.3 Recombinant Protein Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Recombinant Protein Drugs Regional Market Analysis

      • 5.1 Recombinant Protein Drugs Production by Regions
        • 5.1.1 Global Recombinant Protein Drugs Production by Regions
        • 5.1.2 Global Recombinant Protein Drugs Revenue by Regions
      • 5.2 Recombinant Protein Drugs Consumption by Regions
      • 5.3 North America Recombinant Protein Drugs Market Analysis
        • 5.3.1 North America Recombinant Protein Drugs Production
        • 5.3.2 North America Recombinant Protein Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Recombinant Protein Drugs Import and Export
      • 5.4 Europe Recombinant Protein Drugs Market Analysis
        • 5.4.1 Europe Recombinant Protein Drugs Production
        • 5.4.2 Europe Recombinant Protein Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Recombinant Protein Drugs Import and Export
      • 5.5 China Recombinant Protein Drugs Market Analysis
        • 5.5.1 China Recombinant Protein Drugs Production
        • 5.5.2 China Recombinant Protein Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Recombinant Protein Drugs Import and Export
      • 5.6 Japan Recombinant Protein Drugs Market Analysis
        • 5.6.1 Japan Recombinant Protein Drugs Production
        • 5.6.2 Japan Recombinant Protein Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Recombinant Protein Drugs Import and Export
      • 5.7 Southeast Asia Recombinant Protein Drugs Market Analysis
        • 5.7.1 Southeast Asia Recombinant Protein Drugs Production
        • 5.7.2 Southeast Asia Recombinant Protein Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Recombinant Protein Drugs Import and Export
      • 5.8 India Recombinant Protein Drugs Market Analysis
        • 5.8.1 India Recombinant Protein Drugs Production
        • 5.8.2 India Recombinant Protein Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Recombinant Protein Drugs Import and Export

      6 Recombinant Protein Drugs Segment Market Analysis (by Type)

      • 6.1 Global Recombinant Protein Drugs Production by Type
      • 6.2 Global Recombinant Protein Drugs Revenue by Type
      • 6.3 Recombinant Protein Drugs Price by Type

      7 Recombinant Protein Drugs Segment Market Analysis (by Application)

      • 7.1 Global Recombinant Protein Drugs Consumption by Application
      • 7.2 Global Recombinant Protein Drugs Consumption Market Share by Application (2014-2019)

      8 Recombinant Protein Drugs Major Manufacturers Analysis

      • 8.1 Novo Nordisk
        • 8.1.1 Novo Nordisk Recombinant Protein Drugs Production Sites and Area Served
        • 8.1.2 Novo Nordisk Product Introduction, Application and Specification
        • 8.1.3 Novo Nordisk Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Amgen
        • 8.2.1 Amgen Recombinant Protein Drugs Production Sites and Area Served
        • 8.2.2 Amgen Product Introduction, Application and Specification
        • 8.2.3 Amgen Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Sanofi
        • 8.3.1 Sanofi Recombinant Protein Drugs Production Sites and Area Served
        • 8.3.2 Sanofi Product Introduction, Application and Specification
        • 8.3.3 Sanofi Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Eli Lilly
        • 8.4.1 Eli Lilly Recombinant Protein Drugs Production Sites and Area Served
        • 8.4.2 Eli Lilly Product Introduction, Application and Specification
        • 8.4.3 Eli Lilly Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Merck Serono
        • 8.5.1 Merck Serono Recombinant Protein Drugs Production Sites and Area Served
        • 8.5.2 Merck Serono Product Introduction, Application and Specification
        • 8.5.3 Merck Serono Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Ortho Biotech
        • 8.6.1 Ortho Biotech Recombinant Protein Drugs Production Sites and Area Served
        • 8.6.2 Ortho Biotech Product Introduction, Application and Specification
        • 8.6.3 Ortho Biotech Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Roche
        • 8.7.1 Roche Recombinant Protein Drugs Production Sites and Area Served
        • 8.7.2 Roche Product Introduction, Application and Specification
        • 8.7.3 Roche Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Kyowa Hakko Kirin
        • 8.8.1 Kyowa Hakko Kirin Recombinant Protein Drugs Production Sites and Area Served
        • 8.8.2 Kyowa Hakko Kirin Product Introduction, Application and Specification
        • 8.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Pharmingen
        • 8.9.1 Pharmingen Recombinant Protein Drugs Production Sites and Area Served
        • 8.9.2 Pharmingen Product Introduction, Application and Specification
        • 8.9.3 Pharmingen Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Abcam
        • 8.10.1 Abcam Recombinant Protein Drugs Production Sites and Area Served
        • 8.10.2 Abcam Product Introduction, Application and Specification
        • 8.10.3 Abcam Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 GenSci
      • 8.12 SL PHARM
      • 8.13 Dongbao Pharm
      • 8.14 Ankebio
      • 8.15 NCPC
      • 8.16 Heng Rui

      9 Development Trend of Analysis of Recombinant Protein Drugs Market

      • 9.1 Global Recombinant Protein Drugs Market Trend Analysis
        • 9.1.1 Global Recombinant Protein Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Recombinant Protein Drugs Regional Market Trend
        • 9.2.1 North America Recombinant Protein Drugs Forecast 2019-2025
        • 9.2.2 Europe Recombinant Protein Drugs Forecast 2019-2025
        • 9.2.3 China Recombinant Protein Drugs Forecast 2019-2025
        • 9.2.4 Japan Recombinant Protein Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Recombinant Protein Drugs Forecast 2019-2025
        • 9.2.6 India Recombinant Protein Drugs Forecast 2019-2025
      • 9.3 Recombinant Protein Drugs Market Trend (Product Type)
      • 9.4 Recombinant Protein Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Recombinant Protein Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Recombinant Protein Drugs . Industry analysis & Market Report on Recombinant Protein Drugs is a syndicated market report, published as Global Recombinant Protein Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Recombinant Protein Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,772.00
        4,158.00
        5,544.00
        3,234.00
        4,851.00
        6,468.00
        529,515.00
        794,272.50
        1,059,030.00
        291,795.00
        437,692.50
        583,590.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report